Can individualized sunitinib dose and schedule changes optimize outcomes for kidney cancer patients?

Georg A. Bjarnason

Abstract


The recommended starting dose and schedule for sunitinib is 50 mg daily for 28 days, followed by a 14-day break with significant dose reductions to 37.5 mg (75% of starting dose), and then 25 mg (50% of starting dose) on the same schedule (four/two schedule). There are several reasons why these dose and scheduling recommendations may not be optimal for most patients, as outlined below.

Full Text:

PDF


DOI: http://dx.doi.org/10.5489/cuaj.4293
 |  Add comment